Q2 2023 · 13F-HR
Casdin Capital, LLCholdings as filed
Filed 2023-08-14 · accession 0000919574-23-004796
$1.14B
Reported value
41
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 09062W204 | BLFS | BIOLIFE SOLUTIONS INC | $170.6M | 14.9% | 7,721,535 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $116.2M | 10.2% | 1,015,000 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $75.3M | 6.58% | 5,998,574 | Common | SOLE |
| 26886C107 | — | EQRX INC | $73.5M | 6.43% | 39,527,669 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $53.2M | 4.65% | 280,000 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $52.0M | 4.54% | 1,275,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $48.4M | 4.23% | 1,810,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $47.0M | 4.10% | 500,000 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $44.3M | 3.87% | 2,360,571 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $41.4M | 3.62% | 997,017 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $39.2M | 3.42% | 620,000 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $38.4M | 3.35% | 1,300,000 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $37.5M | 3.27% | 6,381,377 | Common | SOLE |
| 148806102 | CTLTEUR | CATALENT INC | $31.2M | 2.73% | 720,000 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $30.8M | 2.69% | 1,700,000 | Common | SOLE |
| 83444K105 | SLGCUSD | SOMALOGIC INC | $29.1M | 2.54% | 12,604,275 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $29.1M | 2.54% | 155,000 | Common | SOLE |
| 57777K106 | MXCT | MAXCYTE INC | $21.6M | 1.89% | 4,715,000 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $20.5M | 1.79% | 2,023,913 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $19.3M | 1.69% | 1,070,000 | Common | SOLE |
| 81663L200 | WGS | GENEDX HOLDINGS CORP | $18.4M | 1.61% | 3,095,511 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $18.2M | 1.59% | 570,000 | Common | SOLE |
| 00288U106 | ABCL | ABCELLERA BIOLOGICS INC | $16.3M | 1.42% | 2,520,000 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $10.1M | 0.89% | 3,206,380 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $9.8M | 0.85% | 2,050,000 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $9.4M | 0.82% | 850,000 | Common | SOLE |
| 90184D100 | TWST | TWIST BIOSCIENCE CORP | $9.2M | 0.80% | 450,000 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $5.4M | 0.47% | 367,175 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $4.8M | 0.42% | 77,500 | Common | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $4.5M | 0.39% | 750,000 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $4.2M | 0.37% | 90,000 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $3.5M | 0.31% | 510,882 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $3.3M | 0.29% | 1,000,000 | Common | SOLE |
| 34385P108 | LAB | STANDARD BIOTOOLS INC | $2.3M | 0.20% | 1,200,000 | Common | SOLE |
| 00091E109 | ABSI | ABSCI CORPORATION | $2.1M | 0.18% | 1,368,260 | Common | SOLE |
| 30223G102 | EXAIEUR | EXSCIENTIA PLC | $1.3M | 0.11% | 213,900 | Common | SOLE |
| 82933R100 | — | SINGULAR GENOMICS SYSTEMS IN | $1.1M | 0.10% | 1,345,722 | Common | SOLE |
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS INC | $860,400 | 0.08% | 23,814 | Common | SOLE |
| 53000N108 | LIANY | LIANBIO | $470,626 | 0.04% | 206,415 | Common | SOLE |
| 50107A104 | KRON1USD | KRONOS BIO INC | $213,003 | 0.02% | 123,839 | Common | SOLE |
| 80880W106 | SCLXUSD | SCILEX HOLDING CO | $130,962 | 0.01% | 23,512 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.